Last update: 14 hours ago

Medication nonadherence common in patients with T2DM

Medications news

Medications

Medication nonadherence common in patients with T2DM

(HealthDay)—Routine urine samples can be used to test for medication adherence in patients with type 2 diabetes, according to a study published in the June issue of Diabetes Care.

14 hours ago

Medications

As more veterans die of opioid overdoses, study shows need to focus beyond prescriptions

A dramatic rise in opioid overdose deaths among American veterans in recent years has happened mainly among veterans dying from heroin and synthetic opioids, a new study shows.

May 22, 2019

Medications

Rising prescription drug costs continue to create tough choices for seniors

(HealthDay)—A solid minority of senior citizens still struggles to afford their prescription medications, a new government report shows.

May 22, 2019

Medications

Training may help patients challenged by high drug costs

Do you think your doctor knows—or cares—what it cost you to get a prescription filled? Even though out-of-pocket costs for medications can be a significant burden, asking patients if they're concerned about it isn't typically ...

May 22, 2019

Medications

Lilly selling half-price version of popular Humalog insulin

A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of soaring insulin prices.

May 22, 2019

Medications

Doctors can estimate patient adherence by simply asking about medication routine

A visit to the doctor's office typically begins with a series of questions, including one about medications. An Iowa State University researcher recommends doctors ask a follow up to that question to make sure patients are ...

May 21, 2019

Medications

Non-Rx fentanyl up in urine tests positive for other drugs

(HealthDay)—An increasing number of urine drug test (UDT) results positive for cocaine or methamphetamine are also positive for nonprescribed fentanyl, according to a study recently published in JAMA Network Open.

May 21, 2019

Medications

Insights into brigatinib's rare side effects may help more lung cancer patients benefit from the drug

Brigatinib is a next-generation ALK inhibitor that earned FDA approval in 2017 as a second-line therapy after treatment with crizotinib for ALK-positive non-small cell lung cancer. Recently, clinical trial results published ...

May 21, 2019

Medications

Dupilumab cuts exacerbations in late-onset asthma

(HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a study presented at the American Thoracic ...

May 21, 2019

Medications

Clinical drug diversion costly to health care organizations

(HealthDay)—U.S. health care organizations lost nearly $454 million due to clinical drug diversion in 2018, according to the 2019 Drug Diversion Digest, released by Protenus Inc.

May 21, 2019

Medications

Improving the use of methadone for drug users with tuberculosis to prevent withdrawal

Drug users on methadone programmes who contract tuberculosis (TB) should receive effective treatment while maintaining the correct level of methadone in their bodies, following a virtual clinical trial by pharmacy researchers ...

May 21, 2019

Medications

CBD reduces craving and anxiety in people with heroin use disorder

Cannabidiol (CBD) reduced cue-induced craving and anxiety in individuals with a history of heroin abuse, suggesting a potential role for it in helping to break the cycle of addiction, according to research conducted at the ...

May 21, 2019

Medications

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.

May 20, 2019

Medications

FDA approves venetoclax for chronic lymphocytic leukemia

(HealthDay)—Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. Food and Drug Administration announced yesterday.

May 17, 2019

Medications

Could hypnotherapy be alternative to opioids for pain?

(HealthDay)—Hypnosis might sound like a magic trick to some, but the therapy can be an effective pain reliever, a new review shows.

May 17, 2019

Medications

Avelumab and axitinib approved for treatment of renal cell carcinoma

(HealthDay)—Avelumab (BAVENCIO) was approved this week for first-line treatment of advanced renal cell carcinoma (RCC) in combination with axitinib, the U.S. Food and Drug Administration announced.

May 17, 2019

Medications

How the Trump prescription for drug prices transparency could make health care well again

When it comes to the prescription drugs America use, too often money is the last thing consumers think about. Formulaic prescription drug ads are part of the reason why.

May 17, 2019

Medications

Nivolumab with ipilimumab: Combination has added benefit in advanced renal cell carcinoma

Renal cell carcinoma is one of the cancers for which the range of promising treatment options has become considerably wider in recent years. In several early benefit assessments since 2013, the German Institute for Quality ...

May 17, 2019

Medications

Dabigatran doesn't beat aspirin for preventing recurrent stroke

(HealthDay)—Dabigatran is not superior to aspirin for preventing recurrent stroke in patients with recent history of embolic stroke of undetermined source, according to a study published in the May 16 issue of the New England ...

May 16, 2019